Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 21.71% is 145% above its 5-year average of 8.87%, near the high end of its 5-year range (5.38%–21.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.01% above its 12-month average of 15.40%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
21.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
15.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
10.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
8.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
3.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-10.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-27.46%
CURRENT VS TTM AVG
+41.01%
CURRENT VS 3Y AVG
+111.19%
CURRENT VS 5Y AVG
+144.90%
CURRENT VS 10Y AVG
+602.09%
CURRENT VS 15Y AVG
+303.01%
CURRENT VS 20Y AVG
+179.06%
SECTOR MEDIAN · HEALTHCARE
8.75%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+148.27%
vs the sector median at left
DexCom, Inc.
Market Cap
$31.97B
Return on Invested Capital (ROIC)
21.71%
TTM Avg
15.40%
3Y Avg
10.28%
5Y Avg
8.87%
Market Cap
$31.77B
Return on Invested Capital (ROIC)
19.18%
TTM Avg
19.41%
3Y Avg
18.01%
5Y Avg
17.23%
Market Cap
$31.70B
Return on Invested Capital (ROIC)
-12.90%
TTM Avg
-4.21%
3Y Avg
-0.54%
5Y Avg
0.75%
Market Cap
$31.22B
Return on Invested Capital (ROIC)
4.28%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$30.78B
Return on Invested Capital (ROIC)
21.63%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$30.60B
Return on Invested Capital (ROIC)
1.34%
TTM Avg
18.13%
3Y Avg
20.89%
5Y Avg
23.01%
Market Cap
$30.01B
Return on Invested Capital (ROIC)
6.94%
TTM Avg
7.96%
3Y Avg
8.07%
5Y Avg
9.18%
Market Cap
$33.52B
Return on Invested Capital (ROIC)
3.25%
TTM Avg
4.01%
3Y Avg
3.42%
5Y Avg
2.30%
Market Cap
$33.94B
Return on Invested Capital (ROIC)
24.71%
TTM Avg
4.06%
3Y Avg
-7.50%
5Y Avg
-13.90%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DexCom, Inc. (DXCM) | $31.97B | 21.71% | 15.40% | 10.28% | 8.87% |
| ResMed Inc. (RMD)vs › | $31.77B | 19.18% | 19.41% | 18.01% | 17.23% |
| Centene Corp. (CNC)vs › | $31.70B | -12.90% | -4.21% | -0.54% | 0.75% |
| Biogen Inc. (BIIB)vs › | $31.22B | 4.28% | 7.71% | 8.64% | 10.90% |
| Zoetis Inc. (ZTS)vs › | $30.78B | 21.63% | 21.87% | 20.30% | 19.27% |
| Waters Corporation (WAT)vs › | $30.60B | 1.34% | 18.13% | 20.89% | 23.01% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.01B | 6.94% | 7.96% | 8.07% | 9.18% |
| Alcon Inc. (ALC)vs › | $33.52B | 3.25% | 4.01% | 3.42% | 2.30% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $33.94B | 24.71% | 4.06% | -7.50% | -13.90% |
| Medline Inc. (MDLN)vs › | $29.41B | 4.05% | 6.03% | 5.27% | 5.27% |
ROIC
21.7%
ROE
38.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 21.71% |
| 2026-03-31 | 18.12% |
| 2025-12-31 | 16.69% |
| 2025-09-30 | 10.88% |
| 2025-06-30 | 9.59% |
| 2025-03-31 | 9.42% |
| 2024-12-31 | 10.25% |
| 2024-09-30 | 12.44% |
| 2024-06-30 | 11.09% |
| 2024-03-31 | 10.95% |
| 2023-12-31 | 9.68% |
| 2023-09-30 | 6.34% |
| 2023-06-30 | 5.76% |
| 2023-03-31 | 6.26% |
| 2022-12-31 | 7.90% |
| 2022-09-30 | 6.31% |
| 2022-06-30 | 5.38% |
| 2022-03-31 | 6.01% |
| 2021-12-31 | 5.53% |
| 2021-09-30 | 9.14% |
| 2021-06-30 | 8.84% |
| 2021-03-31 | 8.24% |
| 2020-12-31 | 8.15% |
| 2020-09-30 | 8.67% |
| 2020-06-30 | 8.13% |
| 2020-03-31 | 8.73% |
| 2019-12-31 | 6.79% |
| 2019-09-30 | -6.64% |
| 2019-06-30 | -9.33% |
| 2019-03-31 | -9.78% |
| 2018-12-31 | -11.00% |
| 2018-09-30 | -0.77% |
| 2018-06-30 | -1.58% |
| 2018-03-31 | -4.25% |
| 2017-12-31 | -5.55% |
| 2017-09-30 | -8.36% |
| 2017-06-30 | -11.38% |
| 2017-03-31 | -22.97% |
| 2016-12-31 | -21.27% |
| 2016-09-30 | -20.38% |
| 2016-06-30 | -30.94% |
| 2016-03-31 | -26.84% |
| 2015-12-31 | -25.11% |
| 2015-09-30 | -28.49% |
| 2015-06-30 | -11.16% |
| 2015-03-31 | -14.16% |
| 2014-12-31 | -14.70% |
| 2014-09-30 | -20.97% |
| 2014-06-30 | -24.62% |
| 2014-03-31 | -31.11% |
| 2013-12-31 | -31.21% |
| 2013-09-30 | -41.34% |
| 2013-06-30 | -56.38% |
| 2013-03-31 | -61.47% |
| 2012-12-31 | -64.24% |
| 2012-09-30 | -72.39% |
| 2012-06-30 | -59.46% |
| 2012-03-31 | -47.47% |
| 2011-12-31 | -42.41% |
| 2011-09-30 | -37.22% |
| 2011-06-30 | -34.41% |
| 2011-03-31 | -83.40% |
| 2010-12-31 | -72.39% |
| 2010-09-30 | -118.55% |
| 2010-06-30 | -94.41% |
| 2010-03-31 | -85.36% |
| 2009-12-31 | -157.76% |
| 2009-09-30 | -131.59% |
| 2009-06-30 | -103.62% |
| 2009-03-31 | -79.83% |
| 2008-12-31 | -168.77% |
| 2008-09-30 | -139.29% |
| 2008-06-30 | -98.15% |
| 2008-03-31 | -75.81% |
| 2007-12-31 | -66.50% |
| 2007-09-30 | -57.28% |
| 2007-06-30 | -54.18% |
| 2007-03-31 | -49.25% |
| 2006-12-31 | -81.88% |
| 2006-09-30 | -72.17% |
| 2006-06-30 | -53.57% |
| 2006-03-31 | -93.06% |
| 2005-12-31 | -65.31% |
